Combo Form 8-K/425   

UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

WASHINGTON, D.C. 20549  

FORM 8-K  

CURRENT REPORT  

Pursuant to Section 13 or 15(d)  

of the Securities Exchange Act of 1934  

Date of Report (Date of Earliest Event Reported): February 26, 2016  

Mylan N.V.  

(Exact name of registrant as specified in its charter)  

  [DATA_TABLE_REMOVED] 

Building 4, Trident Place 

Mosquito Way, Hatfield, Hertfordshire   AL10 9UL 

 (Address of principal executive offices)   (Zip Code)  

+44 (0) 1707 853 000  

(Registrant’s telephone number, including area code)  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  

 x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  

 ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  

 ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  

 ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  

 Item 8.01 Other Events.  

The Mylan N.V. Board received the attached letter from the Dutch and European Investors’ Associations on Friday, February 26, 2016. The Mylan N.V. Board responded with the attached letter sent on Monday, February 29, 2016, which we believe speaks for itself.  

As previously stated, a vote of Mylan N.V. shareholders is not required under applicable Dutch law in connection with the proposed acquisition of Meda.  

 Item 9.01 Financial Statements and Exhibits.  

 (d) Exhibits  

  [DATA_TABLE_REMOVED] 

SIGNATURE  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

  [DATA_TABLE_REMOVED] 

EXHIBIT INDEX  

  [DATA_TABLE_REMOVED]